交易 Bolt Biotherapeutics, Inc. - BOLT CFD
新增到我的最愛- 概括
- 曆史數據
- 活動
- 收入報表
- 資産負債表
- 現金流
- 所有權
交易條件
價差 | 0.0346 | ||||||||
多頭倉位隔夜費用
Long position overnight fee
前往平台 | -0.024874% | ||||||||
空頭倉位隔夜費用
Short position overnight fee
前往平台 | 0.002651% | ||||||||
隔夜費時間 | 21:00 (UTC) | ||||||||
最小成交量 | 1 | ||||||||
貨幣 | USD | ||||||||
保證金 | 20% | ||||||||
股票交易 | United States of America | ||||||||
交易委員會 | 0% |
*Information provided by Capital.com
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 關閉 | 更改 | 變化 (%) | 打開 | 高 | 低 |
---|---|---|---|---|---|---|
Mar 31, 2023 | 1.3577 | 0.0599 | 4.62% | 1.2978 | 1.3677 | 1.2978 |
Mar 30, 2023 | 1.3178 | -0.0199 | -1.49% | 1.3377 | 1.3377 | 1.1979 |
Mar 29, 2023 | 1.2878 | -0.0499 | -3.73% | 1.3377 | 1.3776 | 1.2778 |
Mar 28, 2023 | 1.2978 | -0.0199 | -1.51% | 1.3177 | 1.3377 | 1.2578 |
Mar 27, 2023 | 1.3377 | 0.0399 | 3.07% | 1.2978 | 1.3377 | 1.2978 |
Mar 24, 2023 | 1.3178 | 0.0200 | 1.54% | 1.2978 | 1.3377 | 1.2978 |
Mar 23, 2023 | 1.3078 | -0.0598 | -4.37% | 1.3676 | 1.4076 | 1.3078 |
Mar 22, 2023 | 1.4076 | -0.0599 | -4.08% | 1.4675 | 1.4675 | 1.3776 |
Mar 21, 2023 | 1.4475 | 0.0499 | 3.57% | 1.3976 | 1.4975 | 1.3776 |
Mar 20, 2023 | 1.4176 | 0.0200 | 1.43% | 1.3976 | 1.4376 | 1.3676 |
Mar 17, 2023 | 1.4176 | -0.0499 | -3.40% | 1.4675 | 1.4875 | 1.3976 |
Mar 16, 2023 | 1.4975 | 0.0699 | 4.90% | 1.4276 | 1.5174 | 1.4176 |
Mar 15, 2023 | 1.4675 | 0.0699 | 5.00% | 1.3976 | 1.4975 | 1.3976 |
Mar 14, 2023 | 1.5075 | 0.1099 | 7.86% | 1.3976 | 1.5075 | 1.3976 |
Mar 13, 2023 | 1.3976 | 0.1098 | 8.53% | 1.2878 | 1.4076 | 1.2678 |
Mar 10, 2023 | 1.2678 | -0.1198 | -8.63% | 1.3876 | 1.3877 | 1.2678 |
Mar 9, 2023 | 1.3876 | -0.1298 | -8.55% | 1.5174 | 1.5674 | 1.3677 |
Mar 8, 2023 | 1.5773 | -0.0200 | -1.25% | 1.5973 | 1.5973 | 1.5274 |
Mar 7, 2023 | 1.6073 | 0.0599 | 3.87% | 1.5474 | 1.6273 | 1.5474 |
Mar 6, 2023 | 1.5674 | -0.0898 | -5.42% | 1.6572 | 1.6672 | 1.5174 |
Bolt Biotherapeutics, Inc. Events
时间(协调世界时) (UTC) | 国家 | 事件 |
---|---|---|
No events scheduled |
- 年度
- 每季度
2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|
總收入 | 1.26 | 0.231 | 0.215 | 0 |
收入 | 1.26 | 0.231 | 0.215 | 0 |
總營業費用 | 94.048 | 49.413 | 31.184 | 11.629 |
銷售/一般/行政費用,總計 | 18.393 | 9.056 | 5.182 | 2.209 |
研究與開發 | 75.655 | 40.357 | 26.002 | 9.42 |
營業收入 | -92.788 | -49.182 | -30.969 | -11.629 |
利息收入(費用),非經營淨值 | 0.281 | 0.199 | 0.524 | 0.193 |
其他,淨值 | -6.084 | -11.745 | -0.042 | -0.153 |
稅前淨收入 | -98.591 | -60.728 | -30.487 | -11.589 |
稅後淨收入 | -98.591 | -60.728 | -30.487 | -11.589 |
未計算非常項目前的淨收益 | -98.591 | -60.728 | -30.487 | -11.589 |
淨收入 | -98.591 | -60.728 | -30.487 | -11.589 |
普通股股東可獲收益 (不含非經常性項目) | -98.591 | -60.728 | -30.487 | -11.589 |
普通股股東可獲收益 (含非經常性項目) | -98.591 | -60.728 | -30.487 | -11.589 |
攤薄淨收入 | -98.591 | -60.728 | -30.487 | -11.589 |
攤薄後加權平均股 | 37.3997 | 36.3279 | 34.5218 | 34.5218 |
扣除特別項目的每股攤薄盈利 | -2.63614 | -1.67166 | -0.88312 | -0.3357 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | ||
每股正常攤薄盈利 | -2.63614 | -1.67166 | -0.88312 | -0.3357 |
Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | |
---|---|---|---|---|---|
總收入 | 2.112 | 1.393 | 0.813 | 0.508 | 0.752 |
收入 | 2.112 | 1.393 | 0.813 | 0.508 | 0.752 |
總營業費用 | 24.458 | 24.452 | 24.689 | 27.583 | 24.278 |
銷售/一般/行政費用,總計 | 5.485 | 5.532 | 6.304 | 5.099 | 4.941 |
研究與開發 | 18.973 | 18.92 | 18.385 | 22.484 | 19.337 |
營業收入 | -22.346 | -23.059 | -23.876 | -27.075 | -23.526 |
利息收入(費用),非經營淨值 | 0.587 | 0.395 | 0.198 | -0.082 | 0.131 |
其他,淨值 | 0 | 0 | 0 | 0 | 0 |
稅前淨收入 | -21.759 | -22.664 | -23.678 | -27.157 | -23.395 |
稅後淨收入 | -21.759 | -22.664 | -23.678 | -27.157 | -23.395 |
未計算非常項目前的淨收益 | -21.759 | -22.664 | -23.678 | -27.157 | -23.395 |
淨收入 | -21.759 | -22.664 | -23.678 | -27.157 | -23.395 |
普通股股東可獲收益 (不含非經常性項目) | -21.759 | -22.664 | -23.678 | -27.157 | -23.395 |
普通股股東可獲收益 (含非經常性項目) | -21.759 | -22.664 | -23.678 | -27.157 | -23.395 |
攤薄淨收入 | -21.759 | -22.664 | -23.678 | -27.157 | -23.395 |
攤薄後加權平均股 | 37.4543 | 37.2936 | 37.1279 | 37.3997 | 37.2068 |
扣除特別項目的每股攤薄盈利 | -0.58095 | -0.60772 | -0.63774 | -0.72613 | -0.62878 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常攤薄盈利 | -0.58095 | -0.60772 | -0.63774 | -0.72613 | -0.62878 |
- 年度
- 每季度
2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|
流動資産總額 | 189.16 | 25.361 | 35.9 | 14.1 |
現金和短期投資 | 186.219 | 22.838 | 34.826 | 13.634 |
現金等價物 | 27.383 | 5.542 | 34.826 | 13.634 |
短期投資 | 158.836 | 17.296 | 0 | 0 |
Prepaid Expenses | 2.941 | 2.523 | 1.074 | 0.466 |
Total Assets | 307.718 | 46.542 | 48.447 | 15.975 |
Property/Plant/Equipment, Total - Net | 30.603 | 16.384 | 11.517 | 1.442 |
Property/Plant/Equipment, Total - Gross | 32.848 | 17.623 | 12.162 | 1.856 |
Accumulated Depreciation, Total | -2.245 | -1.239 | -0.645 | -0.414 |
Other Long Term Assets, Total | 2.607 | 4.797 | 1.03 | 0.433 |
Total Current Liabilities | 21.328 | 11.264 | 8.656 | 2.755 |
Accounts Payable | 3.574 | 1.598 | 2.095 | 0.892 |
Accrued Expenses | 14.885 | 8.164 | 5.962 | 1.823 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 0 | 0.04 | ||
Other Current Liabilities, Total | 2.869 | 1.502 | 0.599 | 0 |
Total Liabilities | 57.599 | 46.193 | 16.788 | 3.551 |
Total Long Term Debt | 0 | 0 | 0 | 0 |
Other Liabilities, Total | 36.271 | 34.929 | 8.132 | 0.796 |
Total Equity | 250.119 | 0.349 | 31.659 | 12.424 |
Preferred Stock - Non Redeemable, Net | 105.296 | 77.505 | 28.367 | |
Common Stock | 0.00037 | 0.00036 | 0 | 0 |
Additional Paid-In Capital | 457.43 | 3.452 | 1.825 | 1.241 |
Retained Earnings (Accumulated Deficit) | -206.99 | -108.399 | -47.671 | -17.184 |
Other Equity, Total | -0.32137 | -0.00036 | 0 | 0 |
Total Liabilities & Shareholders’ Equity | 307.718 | 46.542 | 48.447 | 15.975 |
Total Common Shares Outstanding | 37.3997 | 36.3279 | 34.5218 | 34.5218 |
Long Term Investments | 85.348 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
流動資産總額 | 196.088 | 189.16 | 222.488 | 248.151 | 271.21 |
現金和短期投資 | 190.901 | 186.219 | 212.893 | 244.988 | 266.669 |
現金等價物 | 44.021 | 27.383 | 23.649 | 58.302 | 95.481 |
短期投資 | 146.88 | 158.836 | 189.244 | 186.686 | 171.188 |
Prepaid Expenses | 5.187 | 2.941 | 9.595 | 3.163 | 4.541 |
Total Assets | 282.793 | 307.718 | 333.55 | 347.074 | 324.637 |
Property/Plant/Equipment, Total - Net | 29.911 | 30.603 | 30.868 | 30.553 | 15.418 |
Property/Plant/Equipment, Total - Gross | 32.518 | 32.848 | 32.926 | 32.311 | 16.925 |
Accumulated Depreciation, Total | -2.607 | -2.245 | -2.058 | -1.758 | -1.507 |
Long Term Investments | 54.313 | 85.348 | 77.639 | 65.938 | 36.236 |
Other Long Term Assets, Total | 2.481 | 2.607 | 2.555 | 2.432 | 1.773 |
Total Current Liabilities | 19.306 | 21.328 | 23.695 | 19.25 | 12.012 |
Accounts Payable | 4.446 | 3.574 | 5.155 | 1.614 | 2.888 |
Accrued Expenses | 11.412 | 14.885 | 13.333 | 13.306 | 7.622 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 3.448 | 2.869 | 5.207 | 4.33 | 1.502 |
Total Liabilities | 54.399 | 57.599 | 58.637 | 51.178 | 21.389 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Liabilities, Total | 35.093 | 36.271 | 34.942 | 31.928 | 9.377 |
Total Equity | 228.394 | 250.119 | 274.913 | 295.896 | 303.248 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | ||
Common Stock | 0.00037 | 0.00037 | 0.00037 | 0.00037 | 0.00036 |
Additional Paid-In Capital | 460.458 | 457.43 | 454.784 | 452.357 | 436.165 |
Retained Earnings (Accumulated Deficit) | -230.668 | -206.99 | -179.833 | -156.438 | -132.853 |
Other Equity, Total | -1.39637 | -0.32137 | -0.03837 | -0.02337 | -0.06436 |
Total Liabilities & Shareholders’ Equity | 282.793 | 307.718 | 333.55 | 347.074 | 324.637 |
Total Common Shares Outstanding | 37.4713 | 37.3997 | 37.2481 | 37.191 | 36.3318 |
- 年度
- 每季度
2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|
淨收入/起跑線 | -98.591 | -60.728 | -30.487 | -11.589 |
經營活動産生的現金 | -57.066 | -47.308 | -26.343 | -9.872 |
經營活動産生的現金 | 1.193 | 0.611 | 0.335 | 0.302 |
非現金物品 | 19.825 | 15.092 | 1.544 | 0.276 |
已付現金利息 | 0 | 0.004 | ||
營運資金的變化 | 20.507 | -2.283 | 2.265 | 1.139 |
投資活動産生的現金 | -232.201 | -20.592 | -0.508 | -0.29 |
資本支出 | -2.338 | -3.262 | -0.508 | -0.29 |
其他投資現金流量項目,總計 | -229.863 | -17.33 | 0 | 0 |
融資活動産生的現金 | 311.108 | 39.597 | 48.627 | 19.094 |
融資現金流項目 | 0 | 39.303 | 48.595 | 19.113 |
股票的發行(報廢),淨額 | 311.108 | 0.294 | 0.072 | 0.02 |
債務的發行(退還),淨額 | 0 | -0.04 | -0.039 | |
現金淨變化 | 21.841 | -28.303 | 21.776 | 8.932 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | -23.678 | -98.591 | -71.434 | -48.039 | -24.454 |
Cash From Operating Activities | -24.314 | -57.066 | -39.272 | -20.545 | -16.559 |
Cash From Operating Activities | 0.357 | 1.193 | 0.832 | 0.528 | 0.272 |
Non-Cash Items | 4.556 | 19.825 | 16.21 | 12.401 | 8.994 |
Changes in Working Capital | -5.549 | 20.507 | 15.12 | 14.565 | -1.371 |
Cash From Investing Activities | 40.845 | -232.201 | -253.234 | -237.123 | -190.521 |
Capital Expenditures | -0.605 | -2.338 | -1.776 | -0.761 | -0.058 |
Other Investing Cash Flow Items, Total | 41.45 | -229.863 | -251.458 | -236.362 | -190.463 |
Cash From Financing Activities | 0.107 | 311.108 | 310.613 | 310.428 | 297.019 |
Issuance (Retirement) of Stock, Net | 0.107 | 311.108 | 310.613 | 310.428 | 297.019 |
Net Change in Cash | 16.638 | 21.841 | 18.107 | 52.76 | 89.939 |
Financing Cash Flow Items | 0 |
投資者名稱 | 投資者類型 | 流通股百分比 | 持有股份 | 股份變動 | 持有日期 | 換手率 |
---|---|---|---|---|---|---|
Vivo Capital, LLC | Venture Capital | 10.2793 | 3871291 | 0 | 2022-12-31 | MED |
Sofinnova Investments, Inc | Venture Capital | 7.3138 | 2754437 | 0 | 2022-12-31 | MED |
Citadel Advisors LLC | Hedge Fund | 7.3077 | 2752162 | 114 | 2022-12-31 | HIGH |
Pivotal Bioventure Partners Investment Advisor LLC | Investment Advisor | 5.0224 | 1891467 | 0 | 2022-12-31 | LOW |
Engleman Edgar G | Individual Investor | 3.2402 | 1220280 | -57947 | 2022-03-01 | |
Nan Fung Group Holdings Ltd | Corporation | 3.0986 | 1166952 | 0 | 2022-12-31 | LOW |
Newtyn Management, LLC | Hedge Fund | 3.0536 | 1150000 | 550000 | 2022-12-31 | MED |
Samsara BioCapital, LLC | Venture Capital | 2.7858 | 1049153 | 0 | 2022-12-31 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 2.4648 | 928276 | -11993 | 2022-12-31 | LOW |
OrbiMed Advisors, LLC | Investment Advisor/Hedge Fund | 2.0474 | 771059 | 0 | 2022-12-31 | LOW |
Stanford Management Company | Endowment Fund | 1.9106 | 719546 | 0 | 2022-12-31 | MED |
Renaissance Technologies LLC | Hedge Fund | 1.1724 | 441539 | 47681 | 2022-12-31 | HIGH |
Hawkeye Capital Management, LLC | Hedge Fund | 1.102 | 415039 | 0 | 2022-12-31 | MED |
Tang Capital Management, LLC | Hedge Fund | 1.0621 | 400000 | 200000 | 2022-12-31 | MED |
Goldman Sachs & Company, Inc. | Research Firm | 0.7515 | 283028 | 270883 | 2022-12-31 | MED |
Oasis Management Company Ltd. | Investment Advisor/Hedge Fund | 0.7435 | 280000 | 0 | 2022-12-31 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 0.7131 | 268547 | -153412 | 2022-12-31 | LOW |
Millennium Management LLC | Hedge Fund | 0.6463 | 243401 | 125022 | 2022-12-31 | HIGH |
Assenagon Asset Management S.A. | Investment Advisor | 0.5996 | 225816 | -54165 | 2022-12-31 | HIGH |
Bridgeway Capital Management, LLC | Investment Advisor | 0.4981 | 187600 | 74400 | 2022-12-31 | LOW |
差價合約交易計算器
如果您在特定日期(選取一個日期)開立差價合約交易並在不同日期(選取一個日期)關閉交易,計算您的假設盈虧。
交易佣金
0
- 1:1
槓桿
1:1
- 20
- 100
- 500
- 1000
- 10000
投資
交易規模(槓桿 x 投資):
打開
關閉
做空 做多
Industry: | Bio Therapeutic Drugs |
900 Chesapeake Drive
REDWOOD CITY
CALIFORNIA 94063
US
收入報表
- Annual
- Quarterly
人們也觀看
還在尋找值得信賴的經紀商?
加入全球 500.000 多名交易者,選擇與 Capital.com 交易